ConductScience.org, home

Paper7689439

The future of the quinolones.

Andriole VT. Drugs, 1993. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The future of the quinolones. Papers, record 7689439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7689439

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The future of the quinolones.
PubMed
Journal
Drugs
PubMed
Year
1993
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Andriole VTV T

Source PubMed

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
Technology, PharmaceuticalMajor topic
Fluoroquinolones
Humans

Source PubMed

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,316,228Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.Cancer Res1992https://conductscience.org/library/papers/1316228PubMed
21,320,366In vitro activities of five quinolones against Chlamydia pneumoniae.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1320366PubMed
31,329,621Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1329621PubMed
41,650,698Mode of action of the new quinolones: new data.Eur J Clin Microbiol Infect Dis1991https://conductscience.org/library/papers/1650698PubMed
51,622,183Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1622183PubMed
6186,775DNA gyrase: an enzyme that introduces superhelical turns into DNA.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/186775PubMed
7337,300Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/337300PubMed
84,279,300Interactions between twisted DNAs and enzymes: the effects of superhelical turns.J Mol Biol1974https://conductscience.org/library/papers/4279300PubMed
91,323,952Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1323952PubMed
10347,446Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/347446PubMed
111,329,642Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1329642PubMed
12358,918Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/358918PubMed
1314,056,4311,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.J Med Pharm Chem1962https://conductscience.org/library/papers/14056431PubMed
142,992,360DNA topoisomerases.Annu Rev Biochem1985https://conductscience.org/library/papers/2992360PubMed
151,330,419In vitro activity of CP-74667 compared with four other fluoroquinolones.Diagn Microbiol Infect Dis1992https://conductscience.org/library/papers/1330419PubMed
16200,930Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/200930PubMed
171,416,832Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1416832PubMed
18772,446Nalidixic acid and bacterial chromosome replication.Nature1976https://conductscience.org/library/papers/772446PubMed
191,864,295Use of quinolones in treatment of prostatitis and lower urinary tract infections.Eur J Clin Microbiol Infect Dis1991https://conductscience.org/library/papers/1864295PubMed
201,650,363Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage.J Biol Chem1991https://conductscience.org/library/papers/1650363PubMed

See all 29 references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
37,166,011A CcdB toxin-derived peptide acts as a broad-spectrum antibacterial therapeutic in infected mice.EMBO Rep2023https://conductscience.org/library/papers/37166011PubMed
24,705,262Sequencing of bacterial genomes: principles and insights into pathogenesis and development of antibiotics.Genes (Basel)2013https://conductscience.org/library/papers/24705262PubMed
23,119,344Sparfloxacin: An Overview of Its Efficacy in ENT Infections.Indian J Otolaryngol Head Neck Surg1997https://conductscience.org/library/papers/23119344PubMed
22,346,384The new fluoroquinolones: A critical review.Can J Infect Dis1999https://conductscience.org/library/papers/22346384PubMed
17,160,049Antibacterial discovery and development--the failure of success?Nat Biotechnol2006https://conductscience.org/library/papers/17160049PubMed
11,790,155A critical review of the fluoroquinolones: focus on respiratory infections.Drugs2002https://conductscience.org/library/papers/11790155PubMed
10,553,697The future of the quinolones.Drugs1999https://conductscience.org/library/papers/10553697PubMed
9,210,692In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9210692PubMed
8,974,081Inhibition of rat parotid gland growth response induced by chronic isoproterenol following treatment with quinolone antibiotics.Mol Cell Biochem1996https://conductscience.org/library/papers/8974081PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7689439

GET https://conductscience.org/api/papers/v1/7689439/references?page=2